Forward-Looking Statement Disclosure

Certain statements on this website are forward-looking statements, including those that discuss strategies, goals, outlook or other non-historical matters; or project revenues, income, returns or other financial measures. These forward-looking statements speak only as of the date on which they are made, and Rich Pharmaceuticals, Inc.  undertakes no obligation to update or revise any forward-looking statements. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those contained in the statements, including the risks and uncertainties listed under “Forward-looking Information” and “Risk Factors” in Textron’s Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.

Forward-Looking Statement Disclosure

News

March 21st, 2017

Rich Pharmaceuticals To Launch CannCodex, marking its entry into Medicinal Cannabis Industry
View Release

February 28th, 2017

Rich Pharmaceuticals Attracts New Financing Package with GHS Investments, LLC
View Release

September 27th, 2016

Rich Pharmaceuticals, Inc. Announces Quarterly Milestones
View Release

» View All News

Stock Price